|
Volumn 13, Issue 5, 2005, Pages 1791-1797
|
Evaluation of caffeic acid amide analogues as anti-platelet aggregation and anti-oxidative agents
|
Author keywords
Anti oxidation; Anti platelet aggregation; Arachidonic acid; Caffeic anilides
|
Indexed keywords
2 [3 (3,4 DIHYDROXYPHENYL)ACRYLOYLAMINO]BENZOIC ACID ETHYL ESTER;
3 (3,4 DIHYDROXYPHENYL) N (2 FLUOROPHENYL)ACRYLAMIDE;
3 (3,4 DIHYDROXYPHENYL) N (3 FLUOROPHENYL)ACRYLAMIDE;
3 (3,4 DIHYDROXYPHENYL) N (3,4 DIMETHOXYPHENYL)ACRYLAMIDE;
3 (3,4 DIHYDROXYPHENYL) N (4 FLUOROPHENYL)ACRYLAMIDE;
ALPHA TOCOPHEROL;
AMIDE;
ANILIDE;
ANTIOXIDANT;
ANTITHROMBOCYTIC AGENT;
ARACHIDONIC ACID;
CAFFEIC ACID;
CAFFEIC ACID DERIVATIVE;
N (2 BROMOPHENYL) 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE;
N (2 CHLOROPHENYL) 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE;
N (3 BROMOPHENYL) 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE;
N (3 CHLOROPHENYL) 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE;
N (3 CYANOPHENYL) 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE;
N (4 BROMOPHENYL) 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE;
N (4 CHLOROPHENYL) 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE;
SCAVENGER;
TROLOX C;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTIOXIDANT ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG DETERMINATION;
DRUG INHIBITION;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
IC 50;
NONHUMAN;
RABBIT;
THROMBOCYTE AGGREGATION;
VALIDATION PROCESS;
|
EID: 13444291415
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2004.11.055 Document Type: Article |
Times cited : (61)
|
References (26)
|